On June 16, 2020 Goodwin’s Life Sciences group presented the first of four weekly webinars aiming to provide a multidisciplinary outlook on top-of-mind issues facing European life sciences companies in the era of COVID-19.
At this event, Goodwin’s Life Sciences Corporate partner, Robert Puopolo together with Goodwin’s Life Sciences Capital Markets partner, Michael Maline, Stifel Financial Corporation’s Managing Director for Healthcare Investment Banking, Nicholas Moore, Nasdaq’s Director EMEA, Asaf Homossany, and ICR Capital’s Managing Director, Co-Head of Capital Markets, Lee Stettner, discuss issues faced by European life sciences companies when accessing the U.S. capital markets. Topics will included IPOs, follow-on offerings and private placements, as well as issues relating to transaction structures, investor relations, SRO rules and geographic concerns.
View The Recording:
Visit Goodwin’s Coronavirus Knowledge Center, where firm lawyers from across the globe are issuing new guidance and insights to help clients fully understand and assess the ramifications of COVID-19 and navigate the potential effects of the outbreak on their businesses.